Seleniso (Silvio) Medication Guide: Correct Dosage and Administration
As an important therapeutic drug, the dosage of Selinexor (Selinexor) needs to be finely adjusted according to the patient's specific condition and combined medication regimen. The following are Seliniso (Silvio) Instructions for use for different treatment options:
For patients with multiple myeloma (MM), if the XVd regimen is adopted——that is< /span>Selinesol (Civio) In combination with bortezomib and dexamethasone, the recommendedSelinesol (Civio) dose is 100 mgper weekby mouth, once a week on the first day of each week. At the same time, bortezomib is administered via subcutaneous injection at a dose of 1.3 mg/m² once a week, also on the first day of each week, and then stopped for one week after four consecutive weeks. Dexamethasone is administered twice a week, 20 mg each time, on the 1st and 2nd days of each week.

If the /span>80mg, twice a week, orally on the 1 day and the 3 day of the week.
For patients with largeB cell lymphoma (rrDLBCL), selinesol (Sivio) is recommended The dosage is 60mg, twice a week, also on the 1 day and the 3 day of the week.
In all treatment regimens, selinesol (Silvio) should be continued until disease progression occurs or until the patient becomes intolerant of the drug's side effects. During treatment, doctors will flexibly adjust drug dosage and treatment strategies based on the patient's specific condition and drug response to ensure maximum treatment effects and patient safety.
When using Selinisol (Sivio) , patients must strictly follow the doctor's instructions and use the medicine correctly in accordance with the drug instructions and the doctor's guidance. It is strictly forbidden to change the dosage or stop the medicine on your own. If you have any discomfort or questions during the medication, you should consult your doctor immediately and make adjustments according to the doctor's advice. At the same time, regular follow-up visits and monitoring and evaluation by doctors are also important links to ensure that treatment is effective and safe.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)